Home / Resource Library / Real-World Outcomes of Glofitamab therapy in CAR-T naive Patients with Relapsed/Refractory Large B-cell lymphomaReal-World Outcomes of Glofitamab therapy in CAR-T naive Patients with Relapsed/Refractory Large B-cell lymphoma